Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Fig. 1

BCA improves bone loss in db/db mice. A Representative 2D and 3D reconstruction micro-CT figures of knee joints in WT, Model and BCA groups. B Quantitative measurements of tibia trabecular bone including BV/TV, Tb.N, Tb.Th, Tb.Sp and SMI. (Data were presented as mean ± SD. n = 5 per group. Significant differences between the Model and other groups were shown as * (p-value < 0.05), ** (p-value < 0.01), *** (p-value < 0.001) and **** (p-value < 0.0001))

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us